ZYDUSLIFE Zydus Lifesciences Ltd Investments/Divestments Announcement 2023 - Equity, Debt, VC, Private Equity Investments, Joint Ventures, Disinvestments Zydus Lifesciences received final approval from the USFDA for Zinc Sulfate Injection USP, 10 mg/10 mL (1 mg/mL), 30 mg/10 mL (3 mg/mL), and 25 mg/5 mL (5 mg/mL) Pharmacy Bulk Package Vials..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Zydus Lifesciences Ltd